Clinical Trial Update: Study of Bavituximab in Patients With Chronic Hepatitis C Virus Infection [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update showing completion for Bavituximab in patients with chronic hepatitis C virus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Bavituximab (bavituximab)

Snippet

Sponsor: Peregrine Pharmaceuticals | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED